Our study sheds new light on the role of PD-1/PD-L1 pathway in the pathogenesis of different types of GN as the percentages of PD-1+ cells, especially CD19+/PD-1+ cells, were sensitive and specific parameter to determine patients with PGN and NPGN. Here, CD19 is linked to ganglioneuroma.